Resectable Pancreatic Ductal Adenocarcinoma trials recruiting in Washington

Fewer than 3 recruiting trials found.

All Resectable Pancreatic Ductal Adenocarcinoma trials nationally

Cities in Washington

Recruiting trials in Washington

• Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
  NCT07645651 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle